[1] HATA K, ANZAI H, IKEUCHI H, et al. Surveillance colonoscopy for ulcerative colitis-associated colorectal cancer offers better overall survival in real-world surgically resected cases[J]. Am J Gastroenterol, 2019, 114(3):483-489. [2] LUO C X, ZHANG H. The role of proinflammatory pathways in the pathogenesis of colitis-associated colorectal cancer[J]. Mediators Inflamm, 2017, 2017:5126048. [3] SUN W, SHI Y, WANG Z F, et al. Interaction of long-chain non-coding RNAs and important signaling pathways on human cancers (Review)[J]. Int J Oncol, 2018, 53(6):2343-2355. [4] DHANOA J K, SETHI R S, VERMA R, et al. Long non-coding RNA:its evolutionary relics and biological implications in mammals:a review[J]. J Anim Sci Technol, 2018, 60:25. [5] ROBERTS T C, MORRIS K V, WEINBERG M S. Perspectives on the mechanism of transcriptional regulation by long non-coding RNAs[J]. Epigenetics, 2014, 9(1):13-20. [6] GABORY A, JAMMES H, DANDOLO L. The H19 locus:role of an imprinted non-coding RNA in growth and development[J]. Bioessays, 2010, 32(6):473-480. [7] CHEN S W, ZHU J, MA J, et al. Overexpression of long non-coding RNA H19 is associated with unfavorable prognosis in patients with colorectal cancer and increased proliferation and migration in colon cancer cells[J]. Oncol Lett, 2017,14(2):2446-2452. [8] LV J, YU Y Q, LI S Q, et al. Aflatoxin B1 promotes cell growth and invasion in hepatocellular carcinoma HepG2 cells through H19 and E2F1[J]. Asian Pac J Cancer Prev, 2014, 15(6):2565-2570. [9] ZHANG E B, HAN L, YIN D D, et al. c-Myc-induced, long, noncoding H19 affects cell proliferation and predicts a poor prognosis in patients with gastric cancer[J]. Med Oncol, 2014,31(5):914. [10] MA C, NONG K, ZHU H, et al. H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT[J]. Tumour Biol, 2014, 35(9):9163-9169. [11] LI C F, LI Y C, WANG Y, et al. The effect of LncRNA H19/miR-194-5p axis on the epithelial-mesenchymal transition of colorectal adenocarcinoma[J]. Cell Physiol Biochem, 2018, 50(1):196-213. [12] SNIDER A J, BIALKOWSKA A B, GHALEB A M, et al. Murine model for colitis-associated cancer of the colon[J]. Methods Mol Biol, 2016, 1438:245-253. [13] MONKKONEN T, DEBNATH J. Inflammatory signaling cascades and autophagy in cancer[J]. Autophagy, 2018, 14(2):190-198. [14] HUYNH J, CHAND A, GOUGH D, et al. Therapeutically exploiting STAT3 activity in cancer-using tissue repair as a road map[J]. Nat Rev Cancer, 2019, 19(2):82-96 [15] WALDNER M J, FOERSCH S, NEURATH M F. Interleukin-6:A key regulator of colorectal cancer development[J]. Int J Biol Sci, 2012, 8(9):1248-1253. [16] CUI J D, MO J M, LUO M, et al. C-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer[J]. Int J Clin Exp Pathol, 2015, 8(10):12400-12409. [17] TSANG W P, NG E K, NG S S, et al. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer[J]. Carcinogenesis, 2010, 31(3):350-358. [18] AKAO Y, NAKAGAWA Y, NAOE T. Let-7 microRNA functions as a potential growth suppressor in human colon cancer cells[J]. Biol Pharm Bull, 2006, 29(5):903-906. [19] KALLEN A N, ZHOU X B, XU J, et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs[J]. Mol Cell, 2013, 52(1):101-112 [20] SAMPSON V B, RONG N H,HAN J,et al. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells[J]. Cancer Res, 2007, 67(20):9762-9770. |